Pharmacological agents that improve botulinum toxin efficacy in the treatment of spasmodic dysphonia

Botulinum toxin (botox) injection into the thyroarytenoid (TA) muscle is currently the most favored treatment for spasmodic dysphonia. However, results are often inconsistent. The purpose of this study was to identify a fast-acting neuromuscular blocking agent that could mimic botox effects to screen patients for therapy while still in the clinic. If the agent was noninteractive, it could also be injected coincidentally with botox and the resulting changes in voice used to predict the delayed effects due to botox. Evoked electromyography responses were recorded from the TA muscle in animal experiments to determine the time course for neuromuscular depression by botox and three fast-acting blocking agents: lidocaine, tubocurarine, and succinylcholine. Tubocurarine and succinylcholine proved to be suitable screening or predictor agents of botox efficacy, since they were reversible and mimicked botox action. In contrast, lidocaine produced irreversible effects.     

Technique of percutaneous EMG-guided botulinum toxin injection of the larynx for spasmodic dystonia

Percutaneous electromyography (EMG)-guided technique of botulinum toxin (BT) injection of the larynx evolved from similar techniques for extraocular muscle injection in strabismus, as well as from experience with diagnostic laryngeal EMG. This technique permits rapid accurate injection of BT into the laryngeal muscles. Although usually injected into the thyroarytenoid muscle, BT can also be directed to the posterior cricoarytenoid and cricothyroid muscles. Complications are minimal and of short duration.     

The effect of patient factors on response outcomes toBotox treatment of spasmodic dysphonia

Injection of botulinum toxin (Botox) into the laryngeal muscleshas become the treatment of choice for controlling the symptoms of spasmodic dysphonia (SD). Currently, no specific battery of objective tests to assess the outcome is universally accepted. The purpose of this study was to investigate demographic, clinical, and treatment factors with voice outcome following Botox injection. Sixty-eight patients with adductor SD who underwent at least one Botox injection during a 5-year period were studied. Voice outcome measures were made from patient self-reporting scales and included overall vocal quality, length of response, and duration of breathiness. Vocal quality was significantly correlated with the underlying severity of vocal symptoms prior to treatment, incidence of breathiness and unilateral versus bilateral injection. The length of response was greater in males and following bilateral injections. An increased period of breathiness significantly correlated with bilateral injections.     

Expression of Shiga Toxin B Subunit at Cell Surface in E. coli K-12

The three parts(Stx17B, Stx27B and StxB) of Shiga toxin B subunit have been fused into a cell surface exposed loop of the LamB protein at a BamH I site between residues 153 and 154. Western blotting revealed that the three parts of Shiga toxin B subunit could be expressed as the Lamb fusion proteins in E. coli. Indirect immunofluorescence and immunoelectron microscopy analyses showed fusion proteins LamB/Stx17B and LamB/Stx27B could be expressed at cell surface in E. coli, but fusion protein LamB/StxB could not be expressed at cell surface; it was aggregated in cytoplasm and was toxic to host. This expression system provided a new way to construct an oral live vaccine against Shigella dysenteriae 1.     

Natural toxins: risks,regulations and the analytical situation in Europe

Natural toxins in food and feed are considered important food safety issues of growing concern, in particular mycotoxins, phycotoxins and plant toxins. Most scientific developments have occurred in the past few decades in the area of mycotoxins. Formal health risk assessments have been carried out by the Joint Expert Committee on Food Additives of the World Health Organization and the Food and Agriculture Organization. Limits and regulations for mycotoxins in food and feed have been established in many countries, including practically all European countries. An array of (formally validated) analytical methods and (certified) reference materials have become available. Several European research projects, funded by the European Commission and supported by the European Standardization Committee, have significantly contributed to this development. Quantitative methods of analysis for mycotoxins often make use of immunoaffinity cleanup with liquid chromatographic or gas chromatographic separation techniques in combination with various types of detectors, including mass spectroscopy. For screening purposes (bio)sensor-based techniques are among the promising newcomers. For the phycotoxins the situation is less advanced. Formal risk assessments by authoritative international bodies have not been carried out. Methods of analysis, formally validated according to internationally harmonized protocols, are scarce and animal testing still plays a key role in official methodology. The development of the analytical methodology is partly hampered by the limited availability of certain reliable calibrants and reference materials, although this situation is gradually improving. New regulations in the European Union have increased the pressure to develop and validate chemical methods of analysis. Joint efforts in the European context are now directed towards significantly improving this situation, and techniques such as liquid chromatography–mass spectroscopy offer promise in this respect. Both the working group on biotoxins of the European Standardization Committee and the network of National Reference Laboratories for Marine Biotoxins have taken up responsibilities here. The plant toxins are a category of natural toxins, where the situation is the least developed with respect to regulations, validated methods of analysis and reference materials. Yet, their occurrence in a wide range of consumable plant species demands the attention of the analytical community.     

某些海生毒素(TTX、STX)对钠离子通道的作用研究

研究了河豚毒素（TTX）和石房蛤毒素（STX）及其衍生物的电子结构和分子构型．结果表明TTX中的胍基和半缩醛内酯环以及STX中的两个胍基均形成具有一个碳正电中心的两个高极性平面构型，三角形三个顶点的氮和氧原子分别带有大量负电荷．TTX和STX具有相似的电子结构和空间结构．对于TTX和STX及其衍生物的作用机理以及分子构型与毒性之间的关系也进行了讨论．     

THE EXPRESSION OF ENTEROTOXIN A~-B~+ GENE OF V. cholerae IN E. coli

The cloning in E. coli of a cholerae toxin gene that is A~-B~+ has been successfully constructed by using DNA recombinant techniques. E. coli cells carrying the recombinant plasmid pMM-CTB have been shown to produce a large amount of CTB subunits which are secreted as extracellular proteins.     

Ganglioside–liposome immunoassay for the detection of botulinum toxin

A rapid and highly sensitive receptor immunoassay for botulinum toxin (BT) has been developed using ganglioside-incorporated liposomes. Botulism outbreaks are relatively rare, but their results can be very severe, usually leading to death from respiratory failure. To exert their toxicity, the biological toxins must first bind to receptors on the cell surface, and the trisialoganglioside GT1b has been identified as the cell receptor for BT. Therefore, in this study, GT1b was used to prepare the ganglioside–liposomes by spontaneous insertion into the phospholipid bilayer. In a sandwich-based, hybrid receptor immunoassay, BT is detected as a colored band on a nitrocellulose membrane strip, where BT bound to the GT1b-liposomes are captured by anti-BT antibodies immobilized in a band across the strip. The intensity of the colored band can be visually estimated, or measured by densitometry using computer software. The limit of detection (LOD) for BT in the lateral-flow assay system was 15 pg mL^–1, which is comparable to the limits of detection achieved with the most sensitive assays previously reported. However, this rapid assay can be completed in less than 20 min. These results demonstrate that the sandwich assay using GT1b-liposomes for detection of BT is rapid and very sensitive, suggesting the possibility for detecting BT in field screening, simply and reliably, without the need for complex instrumentation.     

Development of an Electrochemical Biosensor for the Rapid Detection of Cholera Toxin Based on Air Stable Lipid Films with Incorporated Ganglioside GM1 Using Graphene Electrodes

The present work describes a miniaturized potentiometric cholera toxin sensor on graphene nanosheets with incorporated lipid films. Ganglioside GM1, the natural cholera toxin receptor, immobilized on the stabilized lipid films, provided adequate selectivity for detection over a wide range of toxin concentrations, fast response time of ca. 5 min, and detection limit of 1 nM. The proposed sensor is easy to construct and exhibits good reproducibility, reusability, selectivity, long shelf life and high sensitivity of ca. 60 mV/decade of toxin concentration. The method was implemented and validated in lake water samples. This novel ultrathin film technology is currently adapted to the rapid detection of other toxins that could be used in bioterrorism.